Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
NGO

Cochrane

Tracked across 9 events · 502 articles · First seen Dec 04, 2025 · Last active Aug 21, 2026

Sentiment
3
Attention
10
Events
9
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 -20
Tech
Impact: Cochrane published a review concluding that anti-amyloid drugs for Alzheimer's disease do not meaningfully help patients, challenging previous claims of their effectiveness.
Apr 16, 2026 · 6 articles
2 30
Business
Impact: GWO partnered with ECITB to align the programme with its safety and technical training standards, reducing duplication.
Jul 15, 2026 · 6 articles
4 10
Tech
Impact: Cochrane, through Rachel Richardson, provided an independent assessment of the study's methodology, reinforcing its scientific rigor.
May 20, 2026 · 20 articles
3 0
Tech
Impact: Rachel Richardson from Cochrane commented that the study does not represent a smoking gun.
Jul 29, 2026 · 21 articles
6 5
Domestic
Impact: Business lobby; head Rain Newton-Smith said business leaders encouraged by devolution plans.
Apr 20, 2026 · 271 articles
3 0
Domestic
Feb 09, 2026 · 7 articles
2 0
Domestic
Feb 10, 2026 · 7 articles
10 0
International
Mar 06, 2026 · 157 articles
6 0
International
Mar 07, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Cochrane live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.